News
Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know
8 Mar 24
Analyst Ratings
HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Maintains $33 Price Target
8 Mar 24
News, Price Target, Analyst Ratings
EyePoint Pharmaceuticals Q4 GAAP EPS $(0.33) Beats $(0.49) Estimate, Sales $14.03M Beat $8.90M Estimate
7 Mar 24
Earnings, News
Earnings Scheduled For March 7, 2024
7 Mar 24
Earnings
A Preview Of EyePoint Pharmaceuticals's Earnings
6 Mar 24
Earnings
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
4 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Mizuho Maintains Buy on EyePoint Pharmaceuticals, Raises Price Target to $39
16 Feb 24
News, Price Target, Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
12 Feb 24
Options
EyePoint Pharmaceuticals Says The Trial Met Its Primary Endpoint With Both EYP-1901 Doses Demonstrating Statistical Non-Inferiority Change In Best Corrected Visual Acuity; The Trial Also Achieved Key Secondary Endpoint
4 Feb 24
Biotech, News, General
EyePoint Pharmaceuticals Announces Two Presentations Of Topline Data With Additional Subgroup Analyses From The Phase 2 DAVIO 2 Clinical Trial Of EYP-1901 For The Treatment Of Wet Age-Related Macular Degeneration
4 Feb 24
Biotech, News, General
Unveiling 7 Analyst Insights On EyePoint Pharmaceuticals
22 Jan 24
Analyst Ratings
JP Morgan Initiates Coverage On EyePoint Pharmaceuticals with Overweight Rating, Announces Price Target of $35
22 Jan 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Lowers Price Target to $33
16 Jan 24
News, Price Target, Analyst Ratings
$30M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
12 Jan 24
Long Ideas, News, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
EyePoint Says First Patient Has Been Dosed In Phase 2 VERONA Clinical Trial Of EYP-1901 For Diabetic Macular Edema
10 Jan 24
News
Press releases
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
7 Mar 24
Earnings, Press Releases
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
27 Feb 24
News, Press Releases
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 Feb 24
Press Releases
EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
3 Feb 24
Health Care, Analyst Ratings, Press Releases
EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31 Jan 24
News, Press Releases
EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema
10 Jan 24
Health Care, Press Releases